Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.215 CAD 2.38% Market Closed
Market Cap: 30m CAD

Wall Street
Price Targets

MBX Price Targets Summary
Microbix Biosystems Inc

Wall Street analysts forecast MBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MBX is 0.51 CAD with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.

Lowest
Price Target
0.505 CAD
135% Upside
Average
Price Target
0.51 CAD
137% Upside
Highest
Price Target
0.525 CAD
144% Upside
Microbix Biosystems Inc Competitors:
Price Targets
ARX
Aroa Biosurgery Ltd
23% Upside
PHARM
Pharming Group NV
49% Upside
2157
Lepu Biopharma Co Ltd
95% Upside
CVAC
CureVac NV
15% Upside
FDMT
4D Molecular Therapeutics Inc
289% Upside
6628
Transcenta Holding Limited
568% Upside
ALCLS
Cellectis SA
78% Upside
688180
Shanghai Junshi Biosciences Co Ltd
25% Downside

Revenue
Forecast

Revenue Estimate
Microbix Biosystems Inc

For the last 12 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 12%. The projected CAGR for the next 3 years is 22%.

12%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Microbix Biosystems Inc

The compound annual growth rate of Microbix Biosystems Inc's operating income for the next 1 year is 141%.

N/A
Past Growth
141%
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Microbix Biosystems Inc

The compound annual growth rate of Microbix Biosystems Inc's net income for the next 3 years is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MBX's stock price target?
Price Target
0.51 CAD

According to Wall Street analysts, the average 1-year price target for MBX is 0.51 CAD with a low forecast of 0.505 CAD and a high forecast of 0.525 CAD.

What is Microbix Biosystems Inc's Revenue forecast?
Projected CAGR
22%

For the last 12 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 12%. The projected CAGR for the next 3 years is 22%.

What is Microbix Biosystems Inc's Operating Income forecast?
Projected CAGR
141%

The compound annual growth rate of Microbix Biosystems Inc's operating income for the next 1 year is 141%.

What is Microbix Biosystems Inc's Net Income forecast?
Projected CAGR
41%

The compound annual growth rate of Microbix Biosystems Inc's net income for the next 3 years is 41%.

Back to Top